amotosalen has been researched along with riboflavin in 19 studies
| Studies (amotosalen) | Trials (amotosalen) | Recent Studies (post-2010) (amotosalen) | Studies (riboflavin) | Trials (riboflavin) | Recent Studies (post-2010) (riboflavin) |
|---|---|---|---|---|---|
| 179 | 18 | 103 | 9,345 | 389 | 3,015 |
| Protein | Taxonomy | amotosalen (IC50) | riboflavin (IC50) |
|---|---|---|---|
| Thiosulfate sulfurtransferase | Homo sapiens (human) | 8.8 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (31.58) | 29.6817 |
| 2010's | 11 (57.89) | 24.3611 |
| 2020's | 2 (10.53) | 2.80 |
| Authors | Studies |
|---|---|
| Andreu, G; Giraud, Ch; Guillevin, L; Korach, JM; Lacaze, C; Schooneman, F; Vaicle, M | 1 |
| Snyder, EL; Wu, YY | 1 |
| Allain, JP; Bianco, C; Blajchman, MA; Brecher, ME; Busch, M; Leiby, D; Lin, L; Stramer, S | 1 |
| McCullough, J | 1 |
| Gathof, BS; Picker, SM; Steisel, A | 1 |
| Gathof, BS; Oustianskaia, L; Picker, SM; Schneider, V | 1 |
| Corash, L | 1 |
| Cauet, A; Martinaud, C; Sailliol, A | 1 |
| Brunskill, SJ; Butler, C; Doree, C; Estcourt, LJ; Hopewell, S; Murphy, MF; Stanworth, S; Trivella, M | 1 |
| Müller, TH; Seltsam, A | 1 |
| Cazenave, JP; D'Alessandro, A; Devine, DV; Gachet, C; Greinacher, A; Lion, N; Prudent, M; Schubert, P; Steil, L; Thiele, T; Tissot, JD; Völker, U; Zolla, L | 1 |
| Abonnenc, M; Canellini, G; Kaiser-Guignard, J; Lion, N; Osselaer, JC; Tissot, JD | 1 |
| Compernolle, V; Devloo, R; Feys, HB; Van Aelst, B; Vandekerckhove, P; Vanhoorelbeke, K | 1 |
| Abonnenc, M; Aliotta, A; Crettaz, D; Lion, N; Prudent, M; Sonego, G; Tissot, JD | 1 |
| Ariëns, RA; Backholer, L; Cardigan, R; Hubbard, T; Wiltshire, M | 1 |
| Doree, C; Estcourt, LJ; Hopewell, S; Malouf, R; Murphy, MF; Stanworth, SJ; Trivella, M | 1 |
| Compernolle, V; Feys, HB; Van Aelst, B | 1 |
| Garban, F; Heddle, NM; McCullough, J; Rebulla, P; van der Meer, PF | 1 |
| Bazhenov, AI; Bogdanova, AS; Borovkova, NV; Bulanov, AY; Chirkova, KS; Dolzhikova, IV; Dombrovskiy, EA; Drozdova, NE; Ganchin, VV; Gintsburg, AL; Godkov, MA; Kamalova, AR; Kostin, AI; Ladygina, EA; Logunov, DY; Lundgren, MN; Petrikov, SS; Shcheblyakov, DV; Shustov, VV; Volkov, SE | 1 |
12 review(s) available for amotosalen and riboflavin
| Article | Year |
|---|---|
[Blood donation].
Topics: Blood Component Transfusion; Blood Donors; Blood Transfusion; France; Furocoumarins; Humans; Infection Control; Photochemistry; Quality Control; Riboflavin; Risk; Safety; Ultraviolet Rays | 2002 |
Safety of the blood supply: role of pathogen reduction.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Aziridines; Bacterial Infections; Blood; Blood Banks; Blood Transfusion; Furocoumarins; Humans; Riboflavin; Virus Diseases | 2003 |
Protecting the blood supply from emerging pathogens: the role of pathogen inactivation.
Topics: Anti-Infective Agents; Blood; Blood Banks; Blood Component Transfusion; Blood Transfusion; Blood-Borne Pathogens; Communicable Disease Control; Detergents; Furocoumarins; Humans; Infections; Methylene Blue; Photosensitizing Agents; Polyamines; Prions; Riboflavin; Risk; Solvents; Time Factors; Transfusion Reaction; Ultraviolet Rays | 2005 |
Pathogen inactivation: a new paradigm for preventing transfusion-transmitted infections.
Topics: Alkylating Agents; Anti-Infective Agents; Blood Banks; Blood Transfusion; Blood-Borne Pathogens; Communicable Disease Control; Detergents; Furocoumarins; Humans; Methylene Blue; Photosensitizing Agents; Randomized Controlled Trials as Topic; Riboflavin; Transfusion Reaction | 2007 |
[Therapeutic plasmas available worldwide].
Topics: Blood Component Transfusion; Blood Donors; Blood Preservation; Blood Safety; Commerce; Detergents; Disasters; France; Freeze Drying; Furocoumarins; Global Health; Health Services Needs and Demand; Hemorrhage; Humans; Leukocyte Reduction Procedures; Methylene Blue; Microbial Viability; Photosensitizing Agents; Plasma; Riboflavin; Solvents; Ultraviolet Rays; Warfare; World Health Organization | 2013 |
Pathogen-reduced platelets for the prevention of bleeding.
Topics: Antisepsis; Blood Platelets; Furocoumarins; Hemorrhage; Humans; Photosensitizing Agents; Platelet Transfusion; Randomized Controlled Trials as Topic; Riboflavin; Ultraviolet Rays | 2013 |
Update on the use of pathogen-reduced human plasma and platelet concentrates.
Topics: Blood Cells; Blood Component Transfusion; Blood Safety; Blood-Borne Pathogens; Clinical Trials as Topic; Cost-Benefit Analysis; Detergents; Double-Blind Method; Furocoumarins; Humans; Intercalating Agents; Methylene Blue; Multicenter Studies as Topic; Photosensitizing Agents; Plasma; Platelet Transfusion; Riboflavin; Risk Assessment; Solvents; Ultraviolet Rays; Virus Inactivation | 2013 |
Proteome changes in platelets after pathogen inactivation--an interlaboratory consensus.
Topics: Bacterial Infections; Blood Banks; Blood Platelets; Blood Preservation; Furocoumarins; Hemostasis; Humans; Parasitic Diseases; Photochemistry; Proteome; Proteomics; Reproducibility of Results; Riboflavin; Ultraviolet Rays; Virus Diseases | 2014 |
The clinical and biological impact of new pathogen inactivation technologies on platelet concentrates.
Topics: Blood Platelets; Furocoumarins; Humans; Platelet Transfusion; Riboflavin; Ultraviolet Rays | 2014 |
Pathogen-reduced platelets for the prevention of bleeding.
Topics: Adult; Antisepsis; Blood Platelets; Child; Disease Transmission, Infectious; Furocoumarins; Hemorrhage; Humans; Photosensitizing Agents; Platelet Transfusion; Randomized Controlled Trials as Topic; Riboflavin; Thrombocytopenia; Ultraviolet Rays | 2017 |
Biomolecular Consequences of Platelet Pathogen Inactivation Methods.
Topics: Blood Banks; Blood Platelets; Blood Preservation; Blood Transfusion; Furocoumarins; Hemostasis; Humans; Neoplasms; Nucleic Acids; Platelet Transfusion; Riboflavin; Signal Transduction; Thrombocytopenia; Ultraviolet Rays | 2019 |
A crosswalk tabular review on methods and outcomes from randomized clinical trials using pathogen reduced platelets.
Topics: Blood Platelets; Disinfection; Furocoumarins; Hematologic Diseases; Humans; Neoplasms; Platelet Transfusion; Randomized Controlled Trials as Topic; Riboflavin; Ultraviolet Rays | 2020 |
7 other study(ies) available for amotosalen and riboflavin
| Article | Year |
|---|---|
Effects of Mirasol PRT treatment on storage lesion development in plasma-stored apheresis-derived platelets compared to untreated and irradiated units.
Topics: Bacteremia; Blood Component Removal; Blood Platelets; Blood Preservation; Cell Survival; Furocoumarins; Gamma Rays; Glucaric Acid; Humans; In Vitro Techniques; L-Lactate Dehydrogenase; Lactates; Platelet Aggregation; Platelet Count; Platelet Transfusion; Riboflavin | 2008 |
Functional characteristics of apheresis-derived platelets treated with ultraviolet light combined with either amotosalen-HCl (S-59) or riboflavin (vitamin B2) for pathogen-reduction.
Topics: Blood Platelets; Blood Preservation; Disinfection; Furocoumarins; Humans; Photosensitizing Agents; Placental Function Tests; Platelet Aggregation; Platelet Count; Plateletpheresis; Riboflavin; Ultraviolet Rays | 2009 |
Bacterial contamination of platelet components: potential solutions to prevent transfusion-related sepsis.
Topics: Bacteria; Bacterial Infections; Blood Platelets; Disinfection; Ficusin; Furocoumarins; Humans; Nucleic Acids; Platelet Transfusion; Riboflavin; Risk Factors; Sepsis; Ultraviolet Rays | 2011 |
Riboflavin and amotosalen photochemical treatments of platelet concentrates reduce thrombus formation kinetics in vitro.
Topics: Blood Platelets; Collagen; Furocoumarins; Humans; Integrin beta3; Photosensitizing Agents; Platelet Activation; Platelet Aggregation; Riboflavin; Thrombosis; Ultraviolet Rays; von Willebrand Factor | 2015 |
In vitro study of platelet function confirms the contribution of the ultraviolet B (UVB) radiation in the lesions observed in riboflavin/UVB-treated platelet concentrates.
Topics: Annexin A5; Blood Buffy Coat; Blood Platelets; Blood Preservation; Dual Specificity Phosphatase 2; Female; Flow Cytometry; Furocoumarins; Glycolysis; Humans; Male; Osmotic Pressure; P-Selectin; Platelet Function Tests; Riboflavin; Time Factors; Ultraviolet Rays | 2015 |
Effects of riboflavin and amotosalen photoactivation systems for pathogen inactivation of fresh-frozen plasma on fibrin clot structure.
Topics: Blood Coagulation; Blood Safety; Fibrin; Furocoumarins; Humans; Photosensitizing Agents; Plasma; Riboflavin; Virus Inactivation | 2016 |
Impact of pathogen reduction methods on immunological properties of the COVID-19 convalescent plasma.
Topics: Antibodies, Neutralizing; Blood Safety; Blood-Borne Pathogens; COVID-19; COVID-19 Serotherapy; Furocoumarins; Humans; Immunization, Passive; Methylene Blue; Plasma; Riboflavin; SARS-CoV-2 | 2021 |